Member Info for HarChris

One thing that's baffling me is why is biosynex valued so low? What I see is a company that was similarly as successful at taking advantage of covid whilst also attacking growth aggressively in a way we could only dream of - Steve then talks of them having a €136m cash position and yet their market cap is currently €190m...

I thought it was just us that was trading close to cash? What am I missing Steve?

Also football clubs tend to struggle to make a profit and are bought by billionaires or massive consortiums more as a plaything than a business investment.

It's not so much that Aldebaran gets it 'wrong', it's that he seems to be terrible at spotting when a share has reached peak sell off and just always predicts it to go lower unless there's a significant stimulus in the immediate future. I'm sure if he is a shorter he starts off with a small profit but is soon wiped out from failing to crystallise time and time again.

Aldebaran is nicknamed the Grim Reaper by many on LSE for his intentionally timed scare mongering one liners.

He also tends to be the latest to the party... a good rule to follow is if he appears on a BB then the share price is probably very close to the bottom.

My word does that guy not fit the stereotype of what a youtube bitcoinhead looks like - I kept expecting him to pull a rabbit out of his hat at any moment!

I'd prefer instis to snap up our shares, reducing the free float whilst leaving the company flush with cash to go aggressively after growth once plans are in place.

One thing this biosynex buying has done is shorten the period between the Jan results and when DA said we would be hearing more about the post covid strategy (April). There's nothing worse on AIM than the expectation of a long news void.

Let's at least be thankful that Biosynex are playing by the rules -today a company I follow Mkango issued a TR1...
Date on which the threshold was crossed: 25th November 21
Date on which issuer notified: 17th February 22 !

https://www.lse.co.uk/rns/MKA/holdings-in-company-n81zvkoyu5v5emj.html

What's the volume been like this week? Is it possible they're at 5 or 6% already?

At some point this will require some sort of comment from the company right? You don't just sit there silently as a competitor accumulates your shares publicly?!

This is a lovely way to end the week and head into the weekend - great timing with the TR1 release once again!

We all know how often the government have u-turned up until now - isn’t it best that we’re in the driving seat if they happen to u-turn again?

For a growing business already trading below NAV a forward P/E of 6.5 is ludicrous.

Oh no byp I thought you'd at least humour us by telling us your buys and sells so we can see how successful you are! Less of this 'maybe I did, maybe I didn't' rhetoric please!

What with possible further TR1s on the way (assuming Biosynex don't just randomly stop at 3%) it keeps attention on us and hopefully helps steady the share price before another move north - very happy personally if this bobs around 200p today.

Arguing that this is good news and the share price ending up flat are not two mutually exclusive things you know byp? Unless one claimed that this was going to fly this morning then there's nothing disingenuous or incorrect about speaking positively re this news. It might slowly convince some on the sidelines that we won't be sitting here like mugs until April in absolute silence, it can be argued that this forms part of the bigger picture, there could well be an interesting link seeing as biosynex are European leaders in POC testing...

After a year of hypothetical virtual trading we're about to find out if your skills translate to the real world! - you sell at 203 or something like that?

The rampers are long gone byp, there are no 'gamechanger' 'BOOM!' 'can't wait til the market opens!' type posts on here anymore...

Still a decent open all the same.

How anyone is trying to twist this into a negative I don't know. Covid revenue has already been written off at today's valuation, we are currently trading close to cash and are given no premium due to the executional risk of the next stage of our development.

Another CTDA approval, this time for promate, whilst we wait to find out more re biosynex activity and the April strategic update is a positive.

Traders weren’t expecting another rns to land so soon that’s for sure…

Don't assume traders are all making money... just as some time the bottom others join at the top!
https://twitter.com/ClownCryptic/status/1493879608227344384

Disappointing close though that's for sure.